In this episode, David interviews Professor Celia Morgan, Ph.D., who holds the Chair of Psychopharmacology and co-leads the Transdisciplinary Psychedelics Group at The University of Exeter. This was recorded on the dawn of UK’s Breaking Convention conference, where Morgan was speaking about the therapeutic potential of ketamine as well as the danger of people developing […]

The post PT419 – Ketamine-Assisted Therapy for Severe Alcohol Use Disorder appeared first on Psychedelics Today.

Previous articleAlgernon Pharmaceuticals Engages Maxim Group to Explore Spin-Off of its Ifenprodil Phase 2 Chronic Cough Drug Development Program
Next articlePharmaTher Initiates Filing of Abbreviated New Drug Application for KETARX™ (racemic ketamine) to the FDA